Related Experiment Video

Updated: Dec 12, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K

B(effector)reaking bad in systemic sclerosis: role of a novel B cell subset

S O'Reilly1, J van Laar2

  • 1Department of Biosciences, Durham University, Durham, UK.

Clinical and Experimental Immunology
|August 13, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.4K

Related Experiment Videos

Last Updated: Dec 12, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.2K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.4K

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.5K
T Cell Types and Functions01:24

T Cell Types and Functions

1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Humoral Immune Responses01:36

Humoral Immune Responses

82.7K
Overview
82.7K

Articles linked to this work by shared authors, journal, and citation graph.

Metabolic reprogramming of CD4⁺ T cells by Zaprinast induces HIV-1 latency reversal ex vivo.

Retrovirology·2026

A review of current and potential applications of macroalgae to equine veterinary science.

Journal of equine veterinary science·2025

CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland.

Irish journal of medical science·2025

The use of sequential multiple assignment randomized trials (SMARTs) in physical activity interventions: a systematic review.

BMC medical research methodology·2024

Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors.

BJC reports·2024

Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer.

Breast cancer research and treatment·2024

Peripheral T-Cell Transitions Following Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis.

Clinical and experimental immunology·2026

Severity-associated changes in ICOS, CD27, CD127 and CLA expression and expansion of virus-specific T Cells in acute dengue.

Clinical and experimental immunology·2026

Tim-3 Upregulation in Monocyte Subsets as a Distinctive Immune Feature and Early Diagnostic Indicator in Systemic Lupus Erythematosus.

Clinical and experimental immunology·2026

Macrophages in tumors with downregulated MHC-I expression: emerging therapeutic opportunities and translational challenges.

Clinical and experimental immunology·2026

Stage-dependent CD40 signalling defines a shift between protective and suppressive immunity in visceral leishmaniasis.

Clinical and experimental immunology·2026

Post-translational modifications in extracellular microvesicles from plasma of rheumatoid arthritis patients following anti-TNFα therapy.

Clinical and experimental immunology·2026

Crosstalk Between Oligodendrocyte Lineage Cells and CNS-Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis.

Glia·2026

Autophagy: Mechanisms and therapeutic perspectives in intestinal metaplasia (Review).

Molecular medicine reports·2026

Diffuse Large B-Cell Lymphoma Masquerading as Cholangiocarcinoma in a Young Adult.

ACG case reports journal·2026

Prognostic Outcomes in Seropositive and Seronegative Autoimmune Encephalitis.

Iranian journal of child neurology·2026

Correction: Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations.

Frontiers in immunology·2026

Interface between inborn errors of immunity and rheumatological disorders in children: A pediatrician's conundrum.

World journal of clinical pediatrics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us